Myositis Autoantibodies Associated With Chronic Course in JIIM
Myositis autoantibodies and some early clinical features are associated with a chronic disease course in juvenile myositis.
Myositis autoantibodies and some early clinical features are associated with a chronic disease course in juvenile myositis.
Tocilizumab was associated with significant improvement in periodontal inflammation in patients with RA.
Which agent—DMARD or biologic—or combination is best for a patient with rheumatoid arthritis?